Table 2 Immunohistochemical findings
From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
Antigen | Total |
|---|---|
CgA | 6/304 (2.0%) |
Syn | 26/304 (8.6%) |
CD56 | 56/189 (29.6%) |
Neuroendocrinea | 70/188 (37.2%) |
HMB-45 | 235/264 (89.0%) |
Melan-A | 199/231 (86.1%) |
S−100 | 224/254 (88.2%) |
SOX10 | 50/55 (90.9%) |
CD117 | 27/39 (69.2%) |
CK | 6/242 (2.5%) |
EMA | 2/63 (3.2%) |
Cam5.2 | 1/49 (2.0%) |
Vimentin | 148/151 (98.0%) |